Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net earnings	$ 94,225	$ 67,877
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation	8,330	8,100
Amortization	15,787	12,820
Deferred income taxes	0	(401)
Noncurrent employee benefits	(12)	(274)
Stock-based compensation expense	4,595	3,963
Changes in:
Receivables	(9,814)	(11,855)
Inventories	(3,367)	(27,628)
Payables	(5,242)	12,282
Prepaid expenses and other assets	(7,772)	(7,279)
Other liabilities	6,237	14,567
Total adjustments	8,742	4,295
Net cash provided by operations	102,967	72,172
Investing activities:
Property, plant and equipment expenditures	(8,149)	(9,949)
Acquisitions, net of cash acquired	(3,000)	(17,127)
Net cash used for investing activities	(11,149)	(27,076)
Financing activities:
Dividends paid	(25,862)	(21,134)
Proceeds from exercise of stock options	751	967
Net cash used for financing activities	(25,111)	(20,167)
Effect of foreign exchange rates on cash	466	(71)
Increase in cash and cash equivalents	67,173	24,858
Cash and cash equivalents - beginning of period	191,782	138,052
Cash and cash equivalents - end of period	$ 258,955	$ 162,910